Our Work
Research briefs for responsible oncology intelligence
OncogenTime documents 16 internal studies and product investigations across AI-assisted case analysis, patient journey intelligence, treatment response, follow-up, secure cloud architecture, interoperability, and responsible AI boundaries.
Research System16 reviewable workstreams
Case summaries
Patient journey
Cloud controls
6 diagnosis-claim studiesResearch posture
Serious product research without overstating validation.
These workstreams are framed as research briefs, prototypes, and product-development investigations. They are framed as university research-stage product work and are not presented as deployed medical advice, regulatory clearance, clinical validation, or guaranteed patient-outcome evidence.
Standalone diagnosis claim boundary
OT-RB-2026-07 through OT-RB-2026-12 are grouped as Standalone diagnosis claims within the university research track. This means the research scope studied standalone diagnostic-claim boundaries, infrastructure, responsible AI review, early-access readiness, multi-center controls, treatment-response mapping, and follow-up intelligence. The wording remains research-stage: these are not deployed medical advice, not regulatory clearance, and not a replacement for clinician judgment.
Research briefs
Current workstreams and product investigations.
Focus: structured oncology case summarization with source-aware sections for diagnosis, staging, molecular context, treatment history, and follow-up.
Status: internal product research brief, early-access roadmap input.
Read brief →
Focus: organizing molecular alterations alongside therapy sequence, response history, and research evidence for clinician review.
Status: concept study for genomics-aware insight modules.
Read brief →
Focus: roadmap analysis for routing imaging references and pathology context into multidisciplinary case review.
Status: roadmap-stage investigation, not a diagnostic imaging claim.
Read brief →
Focus: case preparation, evidence cards, discussion queues, and shared context for multidisciplinary oncology teams.
Status: internal workflow design study.
Read brief →Focus: longitudinal representation of diagnosis, therapy, response, toxicity, recurrence, surveillance, and follow-up context.
Status: product model for timeline and care-journey modules.
Read brief →
Focus: organizing research signals, evidence clusters, and clinical-trial awareness without replacing professional interpretation.
Status: research intelligence product brief.
Read brief →
Focus: privacy-conscious cloud architecture, role-aware access, audit logging, and future integration planning for healthcare organizations.
Status: infrastructure design brief for deployment conversations.
Standalone diagnosis claimsRead brief →Focus: clinician-in-the-loop review, uncertainty language, source traceability, and careful separation of summaries from clinical decisions.
Status: responsible AI operating principle.
Standalone diagnosis claimsRead brief →
Focus: membership model, pricing readiness, product roadmap staging, and feedback loops for clinicians, researchers, and organizations.
Status: commercial roadmap study.
Standalone diagnosis claimsRead brief →Focus: collaboration spaces, organization-level permissions, research workflows, and security boundaries for multi-center programs.
Status: enterprise feature investigation.
Standalone diagnosis claimsRead brief →
Focus: mapping therapy timelines, response observations, biomarker context, and follow-up signals into a reviewable treatment-response workspace.
Status: prototype research brief for response-oriented journey modeling.
Standalone diagnosis claimsRead brief →Focus: organizing surveillance plans, follow-up intervals, unresolved questions, and longitudinal monitoring context for oncology teams.
Status: product research brief for follow-up workflow design.
Standalone diagnosis claimsRead brief →Focus: structuring treatment toxicity, adverse event notes, tolerability context, and follow-up actions for clinician review.
Status: prototype brief for safety-context organization.
Read brief →
Focus: tracking recurrence concerns, surveillance findings, response history, and follow-up questions in a reviewable workflow model.
Status: research brief for recurrence-context workflow design, not risk prediction.
Read brief →
Focus: supporting research review of anonymized oncology cohorts across diagnosis, therapy, response, toxicity, recurrence, surveillance, and follow-up patterns.
Status: research prototype brief for cohort-level analytics and collaboration.
Read brief →Focus: planning interoperable oncology data exchange across diagnosis, therapy, response, toxicity, recurrence, surveillance, follow-up, and research workflows.
Status: infrastructure roadmap brief for interoperability planning.
Read brief →Responsible communication
Research language that does not overclaim.
Every workstream uses product-research language: research brief, prototype, decision-support, clinician-in-the-loop, not medical advice, and not a diagnostic system.
Cloud infrastructure direction
NVIDIA Inception MemberExplore the OncogenTime research roadmap.
Request early access to discuss clinical, research, or healthcare organization workflows.